PMID- 8240799 OWN - NLM STAT- MEDLINE DCOM- 19940106 LR - 20231213 IS - 0958-0670 (Print) IS - 0958-0670 (Linking) VI - 78 IP - 5 DP - 1993 Sep TI - Volume-sensitive KCl co-transport and taurine fluxes in horse red blood cells. PG - 685-95 AB - Potassium (using 86Rb+ as a tracer), amino acid and taurine fluxes were measured in horse red blood cells (RBCs). No volume-sensitive component of alanine and glycine transport was observed, and although volume-sensitive taurine fluxes were observed in most animals, their absolute magnitudes were small. K+ fluxes, however, were shown to be particularly volume sensitive; they were stimulated by cell swelling and inhibited by cell shrinkage. Sizeable fluxes were present at normal cell volumes. The volume-sensitive K+ flux was Cl- dependent and was abolished by Cl- replacement with methylsulphate. The Cl(-)-dependent K+ fluxes in horse red blood cells were stimulated by lowering in external pH to 6.9 and by treatment with the sulphydryl-reacting agent, N-ethylmaleimide. They were inhibited by the potent K(+)-Cl- co-transport inhibitor, DIOA, ([(dihydroindenyl)oxy]alkanoic acid) but were insensitive to the Na(+)-K(+)-Cl- co-transport inhibitors, frusemide and bumetanide. A Cl- channel inhibitor, 5-nitro-2-(phenylpropyl-amino)-benzoate (NPPB), produced partial inhibition. These results suggest that regulatory volume decrease in horse red blood cells is achieved predominantly by volume-sensitive K+ efflux mediated via a K(+)-Cl- co-transport system with similar properties to those observed in the red blood cells of other species. The significance of these findings and their rheological consequences are discussed. FAU - Gibson, J S AU - Gibson JS AD - Department of Veterinary Medicine, University of Cambridge. FAU - Ellory, J C AU - Ellory JC FAU - Culliford, S J AU - Culliford SJ FAU - Fincham, D A AU - Fincham DA LA - eng GR - Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Exp Physiol JT - Experimental physiology JID - 9002940 RN - 0 (((dihydroindenyl)oxy)alkanoic acid) RN - 0 (Carboxylic Acids) RN - 0 (Carrier Proteins) RN - 0 (Indenes) RN - 0 (Symporters) RN - 0Y2S3XUQ5H (Bumetanide) RN - 1EQV5MLY3D (Taurine) RN - 7LXU5N7ZO5 (Furosemide) RN - O3C74ACM9V (Ethylmaleimide) RN - RWP5GA015D (Potassium) SB - IM MH - Animals MH - Bumetanide/pharmacology MH - Carboxylic Acids/pharmacology MH - Carrier Proteins/analysis/*physiology MH - Erythrocyte Volume/*physiology MH - Erythrocytes/chemistry/*metabolism/*physiology MH - Ethylmaleimide/pharmacology MH - Female MH - Furosemide/pharmacology MH - Horses/*blood MH - Humans MH - Hydrogen-Ion Concentration MH - Indenes/pharmacology MH - Male MH - Potassium/metabolism MH - *Symporters MH - Taurine/*metabolism MH - K Cl- Cotransporters EDAT- 1993/09/01 00:00 MHDA- 1993/09/01 00:01 CRDT- 1993/09/01 00:00 PHST- 1993/09/01 00:00 [pubmed] PHST- 1993/09/01 00:01 [medline] PHST- 1993/09/01 00:00 [entrez] AID - 10.1113/expphysiol.1993.sp003716 [doi] PST - ppublish SO - Exp Physiol. 1993 Sep;78(5):685-95. doi: 10.1113/expphysiol.1993.sp003716.